To this purpose, we choose to compare AURKA-PLK1-FOXM1 expression and activating phosphorylation in CD34+ cells purified from bone marrow samples of CML patients at diagnosis and peripheral blood of healthy persons pooled to avoid individual differences [24]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.